Antony A. Riley - 07 Sep 2021 Form 4 Insider Report for Forte Biosciences, Inc. (FBRX)

Role
Chief Financial Officer
Signature
/s/ Paul A. Wagner, Ph.D., as Attorney-in-Fact
Issuer symbol
FBRX
Transactions as of
07 Sep 2021
Net transactions value
-$106,105
Form type
4
Filing time
07 Sep 2021, 16:09:58 UTC
Next filing
18 Jan 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction FBRX Common Stock Sale $91,092 -21,484 -60% $4.24 14,581 07 Sep 2021 Direct
transaction FBRX Common Stock Sale $15,013 -3,516 -24% $4.27 11,065 07 Sep 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.